“We revised the outlook to negative due to a deterioration in financial performance in fiscal 2015 — based on unaudited numbers — and uncertainty about recovery in fiscal 2016,” said S&P analyst Jennifer Soule.
If Clarendon achieves its financial performance target for fiscal 2016, S&P would consider returning its outlook to stable.
More articles on healthcare finance:
Healthcare spending hits $3 trillion under ACA: 10 things to know
Cleveland Clinic sees operating margin slip to 7.2% as investments drag down bottom line
Hospitals in Dallas and Forth Worth file for bankruptcy: 6 things to know
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
